Please login to view this media
- Talk
- UK
IMPACT-Restart: Influence of COVID-19 on Postoperative Mortality and Risk Factors Associated with SARS-CoV-2 after Orthopaedic and Trauma Surgery
Description
In this presentation, Andrew Hall discusses the results of the IMPACT-Restart study, which examines the effects of COVID-19 on postoperative mortality and risk factors associated with SARS-COV-2 infection in patients undergoing orthopedic and trauma surgery. The session is opened by Bob Handley, who welcomes Andrew for his presentation. Andrew begins by explaining the collaborative nature of IMPACT, highlighting its connections with hospitals across 23 countries. He outlines the two main aims of the study: to assess the impact of COVID-19 on mortality in elective and trauma orthopedic surgeries and to identify risk factors for developing COVID after surgery.
The study included data from nine Scottish hospitals over a seven-week period during the onset of the pandemic and utilized a bespoke data collection tool to ensure data accuracy. Andrew shares key findings showing that patients who contracted COVID-19 postoperatively had significantly lower 30-day survival rates compared to those who did not. Notably, 91% of the COVID cases occurred postoperatively, primarily among trauma patients, with only a small percentage being elective surgeries.
Factors contributing to an increased risk of postoperative COVID-19 include age over 77 years, high ASA grade, and specific types of fractures. The presentation concludes with a brief discussion on IMPACT-Restart 2, which focuses on arthroplasty patients. Overall, Andrew suggests that while COVID mortality in the arthroplasty cohort was low, vulnerable patients may benefit from enhanced perioperative care.